Latest Ally Bridge Group (NY) LLC Stock Portfolio
$123Million– No. of Holdings #21
Ally Bridge Group (NY) LLC Performance:
2026 Q1: 7.4%YTD: 7.4%2025: 5.44%
Performance for 2026 Q1 is 7.4%, and YTD is 7.4%, and 2025 is 5.44%.
About Ally Bridge Group (NY) LLC and 13F Hedge Fund Stock Holdings
Ally Bridge Group (NY) LLC is a hedge fund based in New York, NY. On 2026-05-18, the fund reported it's updated stock portfolio. In the 13F Holdings report, Ally Bridge Group (NY) LLC reported an equity portfolio of $123.8 Millions as of 31 Mar, 2026.
The top stock holdings of Ally Bridge Group (NY) LLC are PRAX, NERV, SLNO. The fund has invested 8.5% of it's portfolio in PRAXIS PRECISION MEDICINES I and 8.1% of portfolio in MINERVA NEUROSCIENCES INC.
The fund managers got completely rid off ATAI BECKLEY NV (ATAI) and TAYSHA GENE THERAPIES INC (TSHA) stocks. They significantly reduced their stock positions in ABIVAX SA, INVENTIVA SA (IVA) and EDGEWISE THERAPEUTICS INC (EWTX). Ally Bridge Group (NY) LLC opened new stock positions in COMPASS PATHWAYS PLC (CMPS), TARSUS PHARMACEUTICALS INC (TARS) and CYTOMX THERAPEUTICS INC. (CTMX). The fund showed a lot of confidence in some stocks as they added substantially to SOLID BIOSCIENCES INC (SLDB), PROMIS NEUROSCIENCES INC (PMN) and EUPRAXIA PHARMACEUTICALS INC.
The top stock holdings of Ally Bridge Group (NY) LLC are PRAX, NERV, SLNO. The fund has invested 8.5% of it's portfolio in PRAXIS PRECISION MEDICINES I and 8.1% of portfolio in MINERVA NEUROSCIENCES INC.
The fund managers got completely rid off ATAI BECKLEY NV (ATAI) and TAYSHA GENE THERAPIES INC (TSHA) stocks. They significantly reduced their stock positions in ABIVAX SA, INVENTIVA SA (IVA) and EDGEWISE THERAPEUTICS INC (EWTX). Ally Bridge Group (NY) LLC opened new stock positions in COMPASS PATHWAYS PLC (CMPS), TARSUS PHARMACEUTICALS INC (TARS) and CYTOMX THERAPEUTICS INC. (CTMX). The fund showed a lot of confidence in some stocks as they added substantially to SOLID BIOSCIENCES INC (SLDB), PROMIS NEUROSCIENCES INC (PMN) and EUPRAXIA PHARMACEUTICALS INC.
Ally Bridge Group (NY) LLC Equity Portfolio Value
Last Reported on: 18 May, 2026
Ally Bridge Group (NY) LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Ally Bridge Group (NY) LLC made a return of 7.4% in the last quarter. In trailing 12 months, it's portfolio return was 21.01%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| compass pathways plc | 5,778,850 |
| tarsus pharmaceuticals inc | 5,672,260 |
| cytomx therapeutics inc. | 4,230,000 |
| perspective therapeutics inc | 3,863,740 |
| alumis inc | 3,678,110 |
| urogen pharma ltd | 3,634,190 |
| capricor therapeutics inc | 3,462,530 |
| inhibikase therapeutics inc | 2,226,000 |
New stocks bought by Ally Bridge Group (NY) LLC
Additions
| Ticker | % Inc. |
|---|---|
| solid biosciences inc | 85.43 |
| promis neurosciences inc | 66.13 |
| eupraxia pharmaceuticals inc | 65.97 |
| praxis precision medicines i | 65.02 |
| ovid therapeutics inc | 57.9 |
| soleno therapeutics inc | 19.03 |
Additions to existing portfolio by Ally Bridge Group (NY) LLC
Reductions
| Ticker | % Reduced |
|---|---|
| abivax sa | -51.84 |
| inventiva sa | -50.31 |
| edgewise therapeutics inc | -17.44 |
Ally Bridge Group (NY) LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| atai beckley nv | -7,006,600 |
| taysha gene therapies inc | -2,514,230 |
Ally Bridge Group (NY) LLC got rid off the above stocks
Sector Distribution
Ally Bridge Group (NY) LLC has about 79.9% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 79.9 |
| Others | 20.1 |
Market Cap. Distribution
Ally Bridge Group (NY) LLC has about 2.8% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- SMALL-CAP
- UNALLOCATED
- NANO-CAP
- MICRO-CAP
- MEGA-CAP
| Category | % |
|---|---|
| MID-CAP | 27.8 |
| SMALL-CAP | 22.5 |
| UNALLOCATED | 20.1 |
| NANO-CAP | 16.9 |
| MICRO-CAP | 9.9 |
| MEGA-CAP | 2.8 |
Stocks belong to which Index?
About 23.3% of the stocks held by Ally Bridge Group (NY) LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 76.7 |
| RUSSELL 2000 | 23.3 |
Ally Bridge Group (NY) LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC has 21 stocks in it's portfolio. About 53% of the portfolio is in top 10 stocks. SLNO proved to be the most loss making stock for the portfolio. NERV was the most profitable stock for Ally Bridge Group (NY) LLC last quarter.
Last Reported on: 18 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | whitehawk therapeutics inc | 2.28 | 817,939 | 2,821,890 | unchanged | 0.00 | ||
| ANTX | an2 therapeutics inc | 1.45 | 526,315 | 1,800,000 | new | |||
| ATAI | atai beckley nv | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CAPR | capricor therapeutics inc | 2.80 | 113,899 | 3,462,530 | new | |||
| CMPS | compass pathways plc | 4.67 | 1,045,000 | 5,778,850 | new | |||
| CTMX | cytomx therapeutics inc. | 3.42 | 900,000 | 4,230,000 | new | |||
| EWTX | edgewise therapeutics inc | 4.10 | 161,000 | 5,071,500 | reduced | -17.44 | ||
| IKT | inhibikase therapeutics inc | 1.80 | 1,325,000 | 2,226,000 | new | |||
| IVA | inventiva sa | 3.34 | 745,300 | 4,136,420 | reduced | -50.31 | ||
| NERV | minerva neurosciences inc | 8.06 | 1,655,500 | 9,974,390 | unchanged | 0.00 | ||
| OVID | ovid therapeutics inc | 5.05 | 2,818,460 | 6,256,980 | added | 57.9 | ||
| PMN | promis neurosciences inc | 4.25 | 414,219 | 5,260,580 | added | 66.13 | ||
| PRAX | praxis precision medicines i | 8.54 | 32,810 | 10,571,100 | added | 65.02 | ||
| RLMD | relmada therapeutics inc | 1.18 | 210,525 | 1,465,250 | new | |||
| SLDB | solid biosciences inc | 4.46 | 766,974 | 5,522,210 | added | 85.43 | ||
| SLNO | soleno therapeutics inc | 5.41 | 200,000 | 6,696,000 | added | 19.03 | ||
| TARS | tarsus pharmaceuticals inc | 4.58 | 80,859 | 5,672,260 | new | |||
| TSHA | taysha gene therapies inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| URGN | urogen pharma ltd | 2.94 | 202,124 | 3,634,190 | new | |||
| eupraxia pharmaceuticals inc | 3.86 | 660,375 | 4,781,120 | added | 65.97 | |||